跳至主要内容
临床试验/IRCT20200413047056N1
IRCT20200413047056N1招募中3 期

Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in improving the condition of patients with COVID-19: A randomized clinical trial

Birjand University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • RT-PCR Confirm the infection in the throat swab or sputum or lower respiratory tract samples.
  • Sign the Informed Consent Form on a voluntary basis.
  • Meet any of the following criteria for severe or critical ill conditions:Respiratory rate >=30/min; orRest SPO2<=90%; orPaO2/FiO2<=300mmHg; orRespiratory failure and needs mechanical ventilation; orMultiple organ failure and needs ICU monitoring

排除标准

  • 未提供

研究者

相似试验

Comparison between the efficacy of intravenous... | 临床试验